![](https://scx1.b-cdn.net/csz/news/tmb/2019/1-cholesterol.jpg)
Evinacumab cuts cholesterol levels by half in patients with HoFH
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...
Mar 30, 2020
0
0